Diazepam and droperidol as i.v. premedicants

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Premedication is crucial for managing patient anxiety and improving procedural outcomes.
• Diazepam and droperidol are commonly used agents for sedation and anxiolysis.

Purpose of the Study:

• To evaluate the efficacy and safety of combined intravenous diazepam and droperidol as premedication.
• To compare the effects of different dosages of these agents on patient-reported and physician-observed outcomes.

Main Methods:

• A randomized study involving 240 patients receiving premedication.
• Evaluation of anxiety relief, sedation, recall, patient/physician acceptance, and side effects.
• Comparison of droperidol (10 mg) and diazepam (10 mg) alone versus a combination of droperidol (2.5 mg) and diazepam (5 mg).

Main Results:

• The combination of droperidol 2.5 mg with diazepam 5 mg demonstrated superior ratings across evaluated variables compared to monotherapy.
• Higher doses of droperidol with diazepam increased anxiety.
• Higher doses of diazepam with droperidol led to over-sedation.

Conclusions:

• Low-dose combination premedication with diazepam and droperidol offers an effective and well-tolerated option.
• Dosage optimization is essential to balance efficacy and minimize adverse effects like anxiety or over-sedation.